Biological Activity of Volatiles from Marine and Terrestrial Bacteria by Schulz, Stefan et al.
Mar. Drugs 2010, 8, 2976-2987; doi:10.3390/md8122976
OPEN ACCESS
Marine Drugs
ISSN 1660-3397
www.mdpi.com/journal/marinedrugs
Article
Biological Activity of Volatiles from Marine and
Terrestrial Bacteria
Stefan Schulz 1;?, Jeroen S. Dickschat 1, Brigitte Kunze 2, Irene Wagner-Dobler 2, Randi Diestel 3
and Florenz Sasse 3
1 Institute of Organic Chemistry, University of Braunschweig—Institute of Technology, Hagenring 30,
38106 Braunschweig, Germany; E-Mail: j.dickschat@tu-bs.de (J.S.D.)
2 Research Group Microbial Communication, Helmholtz Center for Infection Research, Inhoffenstrasse
7, 38124 Braunschweig, Germany; E-Mails: brigitte.kunze@helmholtz-hzi.de (B.K.);
irene.wagner-doebler@helmholtz-hzi.de (I.W.-D.)
3 Department of Chemical Biology, Helmholtz Center for Infection Research, Inhoffenstrasse 7, 38124
Braunschweig, Germany; E-Mails: randi.diestel@helmholtz-hzi.de (R.D.);
ﬂorenz.sasse@helmholtz-hzi.de (F.S.)
? Author to whom correspondence should be addressed; E-Mail: Stefan.Schulz@tu-bs.de;
Tel.: +49-531-391-7353; Fax: +49-531-391-5272.
Received: 12 November 2010; in revised form: 7 December 2010 / Accepted: 17 December 2010 /
Published: 22 December 2010
Abstract: The antiproliferative activity of 52 volatile compounds released from bacteria
was investigated in agar diffusion assays against medically important microorganisms and
mouse ﬁbroblasts. Furthermore, the activity of these compounds to interfere with the
quorum-sensing-systems was tested with two different reporter strains. While some of
the compounds speciﬁc to certain bacteria showed some activity in the antiproliferative
assay, the compounds common to many bacteria were mostly inactive. In contrast, some
of these compounds were active in the quorum-sensing-tests. °-Lactones showed a broad
reactivity, while pyrazines seem to have only low intrinsic activity. A general discussion on
the ecological importance of these ﬁndings is given.
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1. Introduction
Marine bacteria are a rich source of natural products with interesting biological and pharmacological
activities [1,2]. While most research on marine bacterial metabolites focusses on compounds with
moderate polarity isolable from fermentation experiments, relatively few volatile compounds from
marine as well as other bacteria are known [3]. Many bacteria, marine or terrestrial, produce
volatiles, but the speciﬁc function of these compounds is known only in few cases. It seems
likely that the volatiles are used either in intra- or inter-speciﬁc communication and/or in the
chemical defence against other microorganisms. Several studies have shown that bacterial volatiles
can indeed inﬂuence the growth of other organisms [4]. Bacterial volatiles can impact, most
often inhibit, the growth of fungi [4–9], but only few studies describe the activities of certain
compounds. Compounds identiﬁed from fungistatic soil bacteria inhibiting spore germination of certain
fungi were acetamide, trimethylamine, 3-methyl-2-pentanone, benzaldehyde, N,N-dimethyloctylamine,
benzothiazole, 1-butanamine, methanamine, phenylacetaldehyde, and 1-decene [10,11]. Benzothiazole,
cyclohexanol, nonanal, decanal, dimethyl trisulﬁde, and 2-ethyl-1-hexanol, the latter most likely an
anthropogenic artefact, identiﬁed from several Pseudomonas strains, were active in inhibiting growth
of the plant pathogen, Sclerotinia sclerotiorum [12]. 1-Undecene and dimethyl disulﬁde (2), released
by several bacteria, were also active [4], despite the fact that the latter proved to be inactive in other
studies [10–12]. Effects on plants have been described for 2,3-butanediol (47) and acetoin (48) which
improve plant growth in Arabidopsis thaliana, and also effects on animals have been described [4]. On
the other hand, reports on interbacterial effects of volatile compounds are rare. Indole acts as a signalling
compound in Escherichia coli [13] and shows effects on other bacteria [14] while volatile carboxylic
acids inhibit spore formation in several pathogenic bacteria [15].
More or less all studies performed so far concentrated on the evaluation of the effects of readily
available compounds. While these studies showed activity in some cases, questions remain about the
activitypotentialofothercomponents. Thevolatilesidentiﬁedsofarcanberoughlydividedintodifferent
groups depending on their occurrence. While there are common compounds produced by many different,
often unrelated bacteria, e.g., dimethyl disulﬁde (52), or at least by certain groups as geosmin (49) and
2-methylisoborneol (50) found in actinobacteria, myxobacteria, and cyanobacteria, some are unique for
certain strains as the lactones 4–11 [3].
In the present study 52 compounds were tested for their biological effects, covering strain or species
speciﬁc compounds (1–44) and commonly occurring ones (45–52). In a ﬁrst set of experiments
we established a general proﬁle of the biological activities of these compounds. Therefore, the
antiproliferative activity with bacteria, fungi, and murine ﬁbroblasts was tested. The antimicrobial
assays were focussed on medically important strains. In a second set of experiments the possibility
of interference with well known bacterial chemical communication channels was probed. In this
context, the compounds were investigated in an assay on bacterial crosstalk [16] to demonstrate whether
they can inﬂuence the known bacterial quorum-sensing signalling pathway via N-acylhomoserine
lactones (AHLs).
The compounds tested (Figure 1) were identiﬁed from different marine bacteria (see Table 1 for
references). Several compounds originally known from terrestrial bacteria are also included to compareMar. Drugs 2010, 8 2978
activities between compounds originating from terrestrial or marine sources. Nevertheless, there is no
clear cut difference in chemistry between terrestrial and bacterial microorganisms. Common compounds
usually occur in both areas.
Figure 1. Compounds used in this study. Acids, alcohols, lactones, ketones, amides,
pyrazines, sulfur compounds, aromatic compounds, and substances commonly occurring as
bacterial volatiles (45–52).
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2. Results and Discussion
Classical agar diffusion assays were performed using the fungi Aspergillus fumigatus,
Botrytis cinerea, and Pythium debaryanum as well as the yeasts Hansenula anomala,
Saccharomyces cerevisiae, and Candida albicans. Furthermore, the bacteria Pseudomonas aeruginosa,
Klebsellia pneumoniae, Staphylococcus aureus, Micrococcus luteus, Mycobacterium phlei and a mutant
of Escherichia coli which is defective in the tolC gene [17] were used as test organisms. The results
are shown in Table 1. Octanoic acid (1) is active against hyphal fungi and yeasts, as are the amides 22
and 23. °-Butyrolactones 4-8 are active against fungi, yeasts, and bacteria, with a large inﬂuence of a
double bond in the ring. Expansion of the ring to ±- (9) or ²-lactones (10 and 11) reduces the activity.
9-Methyl-3-decanol (2), the characteristic component of the headspace volatiles of Myxococcus xanthus,
shows activity against Gram-positive bacteria and the tolC mutant of Escherichia coli, while alcohol
3 only inhibits the sensitive E. coli mutant. Pyrazines (25–32) as well as ketones (12–19) are
largely inactive with the exception of (Z)-15-methylhexadec-12-en-2-one (19), showing broad activity.
S-Methyl benzothioate (35) is the only sulfur containing compound with activity against fungi and yeast,
while all others (32–40) are inactive. 2-Pentylpyridine (41), produced by a Streptomyces strain [18], is
slightly active against S. cerevisiae, E. coli, and K. pneumoniae. In contrast, the latter bacterium and
C. albicans are the only microorganisms furfuryl isovalerate (42) is not active against.Mar. Drugs 2010, 8 2980
Theresultsdiscussedsofarwereobtainedwithcompoundsproducedonlybyspeciﬁcbacterialstrains.
In contrast, the compounds common to many bacteria showed no inhibitory activity. This is even true
for components as dimethyl disulﬁde (52) which showed activity in other assays [4].
Table 1. Agar diffusion inhibition assay. Asf: Aspergillus fumigatus; Boc: Botrytis cinerea;
Caa: Candida albicans; Pyd: Pythium debaryanum; Hna: Hansenula anomala;
Scc: Saccharomyces cerevisiae; tolC: E. coli tolC mutant; Psa: Pseudomonas aeruginosa;
Kbp: Klebsellia pneumoniae; Sta: Staphylococcus aureus; Mcl: Micrococcus luteus;
Myp: Mycobacterium phlei; Amount: amount of compound used in the agar diffusion assay;
mm: diameter of inhibition zone; i: incomplete inhibition; MIC: cytotoxic activity against
L-929 mouse ﬁbroblasts, minimal inhibition concentration; Oc: source.
No Compound Amount Asf Boc Pyd Caa HnaScc tolCPsa KbpSta Mcl MypMIC Oc
¹g mm mm mm mm mm mm mm mm mm mm mm mm ¹mol
1 Octanoic acid 112 10i 20 11i 11i 0 0 0 0 0 0 480 (1)
2 9-Methyl-3-decanol 156 0 0 0 0 12 0 0 8 13 20 560 [19]
3 10-Methylundecan-2-ol 382 0 0 0 0 8 0 0 0 0 0 420 [20]
4 10-Methylundecan-4-olide 416 11 14 0 0 14 0 0 8i 10i 19 430 [21]
5 10-Methylundec-2-en-4-olide 346 15 14 9i 14 17 11i 0 9 8i 11 363 [21]
6 10-Methylundec-3-en-4-olide 218 9i 9 0 10 13 13i 0 8i 8i 12 230 [21]
7 10-Methyldodecan-4-olide 428 8i 10i 0 0 15 12i 0 8i 8i 13 415 [21]
8 10-Methyldodec-2-en-4-olide 140 8i 8 0 9 20 0 0 8 8 10 135 [21]
9 10-Methylundecan-5-olide 250 0 0 0 0 0 0 0 0 0 0 780 [21]
10 9-Methylundecan-6-olide 28 0 0 0 0 8i 0 0 0 0 18i 260 [22]
11 10-Methylundecan-6-olide 30 0 0 0 0 0 0 0 0 0 0 280 [22]
12 6-Ethyl-3-octanone 304 0 0 0 0 0 0 0 0 0 0 >1000 (2)
13 9-Methyl-3-decanone 162 0 0 0 0 9 0 0 0 0 0 590 [19]
14 9-Methyl-1-phenyldecan-1-one 200 0 0 0 0 0 0 0 0 0 0 0 500 [20]
15 3-Methyltridecan-4-one 528 0 0 0 0 0 0 0 0 0 0 510 [20]
16 2-Methyltridec-2-en-4-one 414 0 0 0 8i 0 0 0 0 0 0 405 [20]
17 2-Methyl-4-tetradecanone 488 0 0 0 0 0 0 0 0 0 0 443 [20]
18 (Z)-13-Methyltetradec-8-en-2-one 280 0 0 0 0 0 0 0 0 0 0 257 [23]
19 (Z)-15-Methylhexadec-12-en-2-one 280 8i 9i 0 9 9 12i 0 13i 10 13 73 [23]
20 Isopentyl formamide 524 0 0 0 0 0 0 0 0 0 0 >1000 [20]
21 Isopentyl acetamide 386 0 0 0 0 0 0 0 0 0 0 >1000 [20]
22 3-Methyl-N-(2-phenylethyl)pentanamide 290 12i 13i 15i 0 11 0 0 0 0 0 815 [24]
23 4-Methyl-N-(2-phenylethyl)pentanamide 130 10i 0 10i 0 10i 0 0 0 0 0 365 [24]
24 N-(2-phenylethyl)benzamide 282 0 0 0 0 0 0 0 0 0 0 773 [24]
25 2,5-Diisobutylpyrazine 1322 0 0 0 0 20 0 0 0 0 0 >1000 [25]
26 2-Butyl-3,6-dimethylpyrazine 644 0 0 0 0 10 0 0 0 0 0 >1000 [23]
27 2-Isopropenyl-5-isopropylpyrazine 178 0 0 0 0 0 0 0 0 0 0 680 [26]
28 2-Methoxy-3,6-dimethylpyrazine 217 0 0 0 0 0 0 0 0 0 0 320 [26]
29 2-Methoxy-3,5-diisobutylpyrazine 354 0 0 0 0 10 0 0 0 0 0 >1000 [26]
30 2-Methoxy-3,6-diisobutylpyrazine 354 0 0 0 0 9 0 0 0 0 0 327 [26]Mar. Drugs 2010, 8 2981
Table 1. Cont.
31 2-Methoxy-3,6-di-sec-butylpyrazine 106 0 0 0 0 0 0 0 0 0 0 487 [26]
32 2-Methylsulfanyl-3,6-dimethylpyrazine 916 0 0 0 0 0 0 0 0 0 0 425 [26]
33 4-Methylsulfanyl-2-butanol 220 0 0 0 0 0 0 0 0 0 0 >1000 [23]
34 S-Methyl
3-(Methylsulfanyl)propanethioate
1100 0 0 0 0 0 0 0 0 0 0 >1000 [27]
35 S-Methyl benzothioate 406 10i 11i 10i 0 8i 0 0 0 0 0 >1000 [28]
36 2-Ethyl-5-isobutylthiophene 238 0 0 0 0 0 0 0 0 0 0 >1000 (2)
37 3,3,6,6-Tetramethyl-1,2,5-trithiepane 200 0 0 0 0 0 0 0 0 0 0 0 705 [29]
38 3,3,7,7-Tetramethyl-1,2,5-trithiepane 200 0 0 0 0 0 0 0 0 0 0 0 >1000 [29]
39 3,3,8,8-Tetramethyl-1,2,5,6-tetrathiocane 200 0 0 0 0 0 0 0 0 0 0 0 >1000 [29]
40 3,3,7,7-Tetramethyl-1,2,5,6-tetrathiocane 200 0 0 0 0 0 0 0 0 0 0 0 >1000 [29]
41 2-Pentylpyridine 1198 0 0 0 8i 8 0 8i 0 0 0 >1000 (3)
42 Furfuryl isovalerate 494 11i 15 0 12 8 13 0 13 9 12 62 [26]
43 2-Furanmethanol 200 0 0 0 0 0 0 0 0 0 0 0 >1000 [30]
44 Tropone 200 0 0 0 0 0 0 0 0 0 0 0 >1000 [27,28]
Common Compounds
45 3-Methylbutanol 200 0 0 0 0 0 0 0 0 0 0 0 >1000 [3]
46 2-Phenylethanol 200 0 0 0 0 0 0 0 0 0 0 0 >1000 [21,23,27]
47 (2R,3R)-Butanediol 200 0 0 0 0 0 0 0 0 0 0 0 >1000 [3]
48 Acetoin 200 0 0 0 0 0 0 0 0 0 0 0 >1000 [3]
49 Geosmin 200 0 0 0 0 0 0 0 0 0 0 0 >1000 [21]
50 (+)-R-Methylisoborneol 200 0 0 0 0 0 0 0 0 0 0 0 >1000 [21]
51 (¡)-S-Methylisoborneol 200 0 0 0 0 0 0 0 0 0 0 0 240
52 Dimethyl disulﬁde 200 0 0 0 0 0 0 0 0 0 0 0 >1000 [21]
(1) Occurs in unclassiﬁed myxobacteria [31].
(2) Occurs in Myxococcus xanthus DK 1622 [31].
(3) Occurs in Streptomyces sp. F5 [18].
Additionally, the cytotoxic activity against L-929 mouse ﬁbroblasts was investigated in concentration
dependant assays. The obtained minimal inhibition concentration (MIC) values indicated moderate or
no activity. The most active compounds were furfuryl isovalerate (42, MIC 62 ¹mol/L), the ketone 19
(MIC 73 ¹mol/L), the lactones 10 and 11 (MIC 260 and 280 ¹mol/L), as well as the pyrazine 28 (MIC
320 ¹mol/L). All these compounds were also active in at least some antimicrobial assays except 28.
All compounds were also investigated for their activity in N-acylhomoserine lactone (AHL) mediated
bacterial communication systems (quorum-sensing). These test were performed using green ﬂuorescent
protein (gfp) equipped reporter strains capable of sensing AHLs with certain side chain speciﬁcity. The
used E. coli MT102 (pJBA132) reporter shows the highest sensitivity for N-(3-oxohexanoyl)homoserine
lactone (3-oxo-C6-AHL) [32], while the Pseudomonas putida F117 (pKR-C12) reporter is very sensitive
to N-(dodecanoyl)homoserine lactone (C12-AHL) [33]. The corresponding AHLs were added to the
sensor strains together with the test compound and the resulting reduction or increase of ﬂuorescence
was recorded (Table 2). Values of more than 50% were considered signiﬁcant.
Several compounds were able to modify the sensor response. The lactones 5–9 inhibited the response
of the C12-AHL sensor. Especially the ±-lactone 9 was highly active. In contrast, the 3-oxo-C6-AHL
sensor showed a different behavior. In particular 4 and 7 stimulated this sensor. This inﬂuence may be
due to the structural similarity between the lactones and the AHLs. Ketones also proved to be active,Mar. Drugs 2010, 8 2982
with 15, 16, 18, 19, and the related alcohol 3 reducing activity of the C12-AHL sensor, while 17 did
so with the 3-oxo-C6-AHL sensor, as did the pyridine derivative 41. The sulfur containing ester 34
and furfuryl isovalerate (42), also one of the most active compounds in the antimicrobial assays, were
the only compounds able to reduce the activity of both sensors. In this assay also compounds common
to many different bacteria showed some activity, reducing the effectivity of the 3-oxo-C6-AHL sensor.
These compounds were the alcohols 45 and 46, and both enantiomers of methylisoborneol (50 and 51).
In summary, 25% of the compounds were able to reduce activity of the C12-AHL sensor, while 19%
show inhibitory activity against 3-oxo-C6-AHL and 13% enhanced its activity.
Table 2. Acylhomoserine lactone assay using N-3-oxohexanoylhomoserine lactone for
E. coli MT102 (C6-AHL) and N-dodecanoylhomoserine lactone for P. putida F117
(C12-AHL). The maximum reduction relative to the native ligand is reported (%). Negative
values indicate no inhibition, but increase of the ﬂuorescence induction. Here the maximum
induction rate relative to the native ligand (100%) is given.
No Compound Conc. C12-AHL C6-AHL
µg/mL % %
1 Octanoic acid 140 23 15
2 9-Methyl-3-decanol 250 6 ¡198
3 10-Methylundecan-2-ol 477 60 3
4 10-Methylundecan-4-olide 500 7 ¡550
5 10-Methylundec-2-en-4-olide 432 59 ¡40
6 10-Methylundec-3-en-4-olide 272 52 ¡16
7 10-Methyldodecan-4-olide 535 71 ¡70
8 10-Methyldodec-2-en-4-olide 175 61 ¡32
9 10-Methylundecan-5-olide 312 82 15
10 9-Methylundecan-6-olide 35 20 12
11 10-Methylundecan-6-olide 37 26 41
12 6-Ethyl-3-octanone 250 ¡15 ¡39
13 9-Methyl-3-decanone 250 10 ¡115
14 9-Methyl-1-phenyldecan-1-one 500 1 ¡27
15 3-Methyltridecan-4-one 660 59 ¡3
16 2-Methyltridec-2-en-4-one 517 52 ¡9
17 2-Methyl-4-tetradecanone 610 46 53
18 (Z)-13-Methyltetradec-8-en-2-one 315 56 ¡18
19 (Z)-15-Methylhexadec-12-en-2-one 315 82 17
20 Isopentyl formamide 655 26 34
21 Isopentyl acetamide 482 15 31
22 3-Methyl-N-(2-phenylethyl)pentanamide 362 12 18
23 4-Methyl-N-(2-phenylethyl)pentanamide 162 ¡13 19Mar. Drugs 2010, 8 2983
Table 2. Cont.
24 N-(2-phenylethyl)benzamide 350 28 49
25 2,5-Diisobutylpyrazine 500 ¡5 ¡94
26 2-Butyl-3,6-dimethylpyrazine 500 13 40
27 2-Isopropenyl-5-isopropylpyrazine 222 35 72
28 2-Methoxy-3,6-dimethylpyrazine 500 40 60
29 2-Methoxy-3,5-diisobutylpyrazine 250 10 ¡92
30 2-Methoxy-3,6-diisobutylpyrazine 500 26 ¡102
31 2-Methoxy-3,6-di-sec-butylpyrazine 132 33 36
32 2-Methylsulfanyl-3,6-dimethylpyrazine 500 5 31
33 4-Methylsulfanyl-2-butanol 275 26 32
34 S-Methyl 3-(Methylsulfanyl)propanethioate 1375 54 85
275 40
35 S-Methyl benzothioate 500 ¡2 46
36 2-Ethyl-5-isobutylthiophene 250 ¡25 ¡180
37 3,3,6,6-Tetramethyl-1,2,5-trithiepane 500 ¡22 51
38 3,3,7,7-Tetramethyl-1,2,5-trithiepane 500 25 18
39 3,3,8,8-Tetramethyl-1,2,5,6-tetrathiocane 500 46 39
40 3,3,7,7-Tetramethyl-1,2,5,6-tetrathiocane 250 30 20
41 2-Pentylpyridine 1497 29 78
42 Furfuryl isovalerate 617 56 84
43 2-Furylmethanol 500 22 46
44 Tropone 500 29 36
Common Compounds
45 3-Methylbutanol 500 13 61
250 14
46 2-Phenylethanol 500 45 69
250 23
50 31
47 (2R,3R)-Butanediol 500 ¡14 7
48 Acetoin 500 23 23
49 Geosmin 500 13 21
50 (+)-R-Methylisoborneol 250 3 69
25 17
51 (¡)-S-Methylisoborneol 500 12 75
250 24
50 10
52 Dimethyl disulﬁde 500 17 26
The concentration of the compounds used in the sensor tests was quite high and dilution experiments
usually led to reduced activity (see Table 2). The concentration of compounds released by bacteria can
be quite high close to the bacterial membrane, their point of release. Therefore, nearby other bacteriaMar. Drugs 2010, 8 2984
might well experience relatively high concentrations of such metabolites, pointing to the possibility that
these compounds might have ecological relevance for known bacterial communication channels.
In summary, the results show that bacterial volatiles can, despite their relatively small size, inﬂuence
different biological traits. Often it is not clear why bacteria produce volatiles. One interesting
observation is that some special compounds produced by only few organisms can have antimicrobial
activity and therefore might ensure survival of the bacterium when under competition with other bacteria.
Contrary to polar and larger compounds they are transported by air and are useful for bacteria under
certain conditions, but can also travel in water with high velocity because of their small size. The
volatiles can also interfere with bacterial communication channels and are ideally suited for being
signalling compounds by themselves. Their potential receptors are not known because only few bacterial
communication mechanisms have been established so far (see Introduction). Finally, in some cases they
may also serve as a means of detoxiﬁcation, as recently proposed for some pyrazines[34]. Interestingly,
the pyrazines show almost no antimicrobial activity. The activity of the volatiles against proliferative
cells can be regarded as quite low with the exception of furfuryl isovalerate, a surprisingly active
compound in several aspects.
Finally, there is no clear difference in activity between volatiles produced by marine or terrestrial
bacteria. The current known origin of the these compounds from bacteria either of terrestrial or marine
habitats is probably pure chance. Most likely terrestrial strains will be found in the future that produce
compounds only known from marine sources so far, e.g., sulfur compounds 37–40, and vice versa.
Insummary, wehaveshownthatbacterialvolatilescanhaveamultitudeofactivities. Theirproduction
has to be taken into account in future studies, especially when researching aspects of the bacterial
chemical communication systems and their chemical defence.
3. Experimental Section
3.1. Antimicrobial assay
Antimicrobial activities were determined by agar diffusion assays using paper discs of 6 mm diameter
soakedwith20¹Lofmethanolicsolutionofthetestcompound. MicroorganismsfromtheHZIcollection
were grown on standard media and seeded into liquid agar medium to a ﬁnal O.D. of 0.01 (bacteria) or
0.1 (yeasts). Spores of fungi were seeded according to experience. Plates were incubated at 30 ◦C and
the diameter of resulting inhibition zones were measured after 1 or 2 days.
3.2. Cell proliferation assay
L-929 mouse ﬁbroblasts were obtained from the German Collection of Microorganisms and Cell
Cultures (DSMZ) and cultivated at 37 ◦C and 10% CO2 in DME medium (high glucose) supplemented
with 10% fetal calf serum. Inhibition of proliferation was measured in microtiter plates. 60 ¹L of
serial dilutions of the test compounds were given to 120 ¹L of the suspended cells (50,000/mL) in
wells of 96-well plates. After 5 days growth each well was judged visually under the microscope. The
lowest concentration of a compound that led to a clearly reduced growth is given as minimal inhibitory
concentration (MIC).Mar. Drugs 2010, 8 2985
3.3. Acylhomoserine lactone sensors
The AHL biosensor strains E. coli MT102 (pJBA132) and Pseudomonas putida F117 (pRK-C12)
were grown in Luria-Bertani (LB) medium with 25 ¹g/mL tetracycline at 37 ◦C and with 20 ¹g/mL
gentamycin at 30 ◦C, respectively. Overnight cultures (50 mL) of the strains were diluted with the same
volume of fresh medium, incubated for about one more hour and adjusted to an OD620 of 1.0. Aliquots
(100 ¹L) of these cultures were transferred by pipet into 96-well microtiter plates which contained
90 ¹L of LB medium, and 5 ¹L of the test compounds in the concentrations reported in Table 2. To
test the compounds for inhibitory activity on quorum-sensing, the sample wells contained 5 ¹L of the
corresponding AHL N-3-oxohexanoylhomoserine lactone for E. coli MT102, N-dodecanoylhomoserine
lactone for P. putida F117) at a concentration of 0.25 ¹g/mL. Samples containing only the corresponding
AHL without test compound were used as positive control and samples containing solvent (10 ¹L) alone
were used as negative control. The microtiter plates were incubated at 30 ◦C with shaking. After 0, 4,
8, and 24 h growth at an OD620 nm, ﬂuorescence (excitation wavelength 485 nm, detection wavelength
of 535 nm) was determined in a Victor 1420 Multilabel Counter (Perkin Elmer). Fold induction of
ﬂuorescence in the test samples was calculated by dividing their speciﬁc ﬂuorescence (gfp535/OD620)
by the speciﬁc ﬂuorescence of the negative control. Relative activity was calculated by comparing the
fold induction of positive control samples (only homoserine lactones) to samples containing samples
with test compounds and the corresponding homoserine lactone.
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